Extrawell Pharmaceutical Holdings Limited reported earnings results for the half year ended September 30, 2021. For the half year, the company reported sales was HKD 43.46 million compared to HKD 36.75 million a year ago. Net income was HKD 88.59 million compared to HKD 74.99 million a year ago. Basic earnings per share from continuing operations was HKD 0.0371 compared to HKD 0.0314 a year ago. Diluted earnings per share from continuing operations was HKD 0.0288 compared to HKD 0.0244 a year ago.